Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)

Cancer Causes and Control

Volumn 11, Issue 9, 2000, Pages 847-852

  Ahonen, M H ^a   Tenkanen, L ^a   Teppo, L ^a   Hakama, M ^a   Tuohimaa, P ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Andropause; Epidemiology; Prostate cancer; Risk factor; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; VITAMIN D RECEPTOR;

ADULT; ARTICLE; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CASE CONTROL STUDY; CONTROLLED STUDY; FINLAND; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REGRESSION ANALYSIS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AGE FACTORS; CASE-CONTROL STUDIES; COHORT STUDIES; FINLAND; HUMAN; MALE; MIDDLE AGE; PROSTATIC NEOPLASMS; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 0033785622     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008923802001     Document Type: Article

References (24)

1. Vitamin D and prostate cancer
2. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis)
3. Geographic patterns of prostate cancer mortality
4. Vitamin D and prostate cancer: A prediagnostic study with stored sera
5. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States)
6. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer
7. Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States)
8. Clinical counterpoint: Vitamin D: New actions, new analogs, new therapeutic potential
9. Vitamin D and prostate cancer: 1,25-dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines
10. Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cancer cells
11. Localization of 1,25-dihydroxyvitamin D3 receptor (VDR) expression in human prostate
12. Human prostate cancer cells: Inhibition of proliferation by vitamin D analogs
13. 1α,25-dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells
14. Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue R for androgen-promoted carcinomas of the rat seminal vesicle and prostate
15. Radioligand receptor assay for 25-hydroxyvitamin D and 1α,25-dihydroxyvitamin D2/D3
16. 3
17. Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
18. Fat-soluble vitamins, vitamin D
19. Stability of vitamin D metabolites in human blood serum and plasma
20. Testosterone and andropause: The feasibility of testosterone replacement therapy in elderly men
21. Androgen receptor and vitamin D receptor in human ovarian cancer: Growth stimulation and inhibition by ligands
22. The role of the vitamin D endocrine system in health and disease
23. 2 as therapeutic agents for prostate cancer
24. Redefining vitamin D insufficiency